In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

GSK improves position in emerging markets with Egyptian buy

Executive Summary

Bristol-Myers Squibb has sold its mature products business in Egypt to GlaxoSmithKline for $210mm. The acquisition gives GSK a leading position with a 9% share of this emerging pharmaceutical market, which is worth approximately $2.1bn.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Payment Includes Cash
    • Divestiture/Spin-Out

Related Companies

Advertisement
UsernamePublicRestriction

Register